Detalhe da pesquisa
1.
Randomized phase III GnG study on two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and double-blinded intensive post-remission therapy with or without glasdegib in patients with newly diagnosed acute myeloid leukemia.
Haematologica
; 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38385304
2.
Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens.
Haematologica
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38654660
3.
Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia.
Haematologica
; 108(8): 2059-2066, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36815361
4.
A German-Wide Systematic Study on Mobilization and Collection of Hematopoietic Stem Cells in Poor Mobilizer Patients with Multiple Myeloma prior to Autologous Stem Cell Transplantation.
Transfus Med Hemother
; 50(6): 475-490, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38089497
5.
Mobilization and Hematopoietic Stem Cell Collection in Poor Mobilizing Patients with Lymphoma: Final Results of the German OPTIMOB Study.
Transfus Med Hemother
; 50(5): 403-416, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37899991
6.
Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative study.
Haematologica
; 106(12): 3100-3106, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34047178
7.
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial.
Lancet Oncol
; 16(16): 1691-9, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26549589
8.
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma.
J Clin Oncol
; 42(1): 26-37, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37753960
9.
Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma- the study protocol of the Adrisk trial.
Front Oncol
; 13: 1128176, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37025596
10.
Q-HAM: a multicenter upfront randomized phase II trial of quizartinib and high-dose Ara-C plus mitoxantrone in relapsed/refractory AML with FLT3-ITD.
Trials
; 24(1): 591, 2023 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37715270
11.
Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial.
J Hematol Oncol
; 16(1): 79, 2023 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37481608
12.
Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry.
J Cancer Res Clin Oncol
; 149(8): 4611-4621, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36167894
13.
[Complete remission of multiple brain metastases of non-small cell lung cancer induced by gefitinib monotherapy]. / Komplette Remission multifokaler zerebraler Metastasen bei chemotherapierefraktärem NSCLC durch Monotherapie mit Gefitinib.
Strahlenther Onkol
; 187(12): 826-30, 2011 Dec.
Artigo
em Alemão
| MEDLINE | ID: mdl-22127359
14.
Evidence for a causal association for HPV in head and neck cancers.
Eur Arch Otorhinolaryngol
; 268(11): 1541-7, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21792686
15.
An analysis of totally implantable central venous port system infections in an urban tertiary referral center.
J Chemother
; 33(4): 228-237, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33030416
16.
Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML.
Trials
; 22(1): 765, 2021 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34732236
17.
Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial.
Leukemia
; 35(9): 2517-2525, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33603142
18.
The Potential of Tumor Debulking to Support Molecular Targeted Therapies.
Front Oncol
; 10: 801, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32626653
19.
Modern treatment options for elderly patients with multiple myeloma.
Onkologie
; 31(6): 335-42, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18547977
20.
Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trial.
Leukemia
; 36(3): 885-888, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34732857